Venrock Healthcare Capital Partners III and Affiliates Report Acquisition of $37.65 Million in Lycia Therapeutics Common Shares
Bitget2026/10/27 22:38- Venrock-affiliated funds reported beneficial ownership of 6,825,233 Lycia Therapeutics common shares.
- Purchases included 1,944,444 common shares at $18 per share.
- Conversion of Series C Preferred Stock and Series D Preferred Stock added 4,779,793 common shares.
- Bong Y. Koh and Nimish P. Shah were listed as reporting 10% owners.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Silver Price Forecast: XAG/USD trades flat around $53 ahead of US inflation data
Swiss Franc holds ground as US Dollar consolidates ahead of CPI inflation data
Net profit surges fivefold but masks decline in core business; crypto mining companies' shift to AI poses hidden risks
Marathon Holdings' Q3 net profit reached $632 million, up 413% year-on-year. However, its mining revenue declined by 35%. The company relied on selling 13,500 BTC to pay off debts and is now betting on AI infrastructure, increasing the risk of an imbalanced profit structure.
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Crypto prices
More
